FUNCTIONAL EVIDENCE FOR DIFFERENT ENDOTHELIN RECEPTORS IN THE LUNG

被引:29
作者
LIPPTON, HL
HAUTH, TA
COHEN, GA
HYMAN, AL
机构
[1] LOUISIANA STATE UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NEW ORLEANS,LA 70112
[2] TULANE UNIV,SCH MED,DEPT SURG,NEW ORLEANS,LA 70112
[3] TULANE UNIV,SCH MED,DEPT PHARMACOL,NEW ORLEANS,LA 70112
[4] TULANE UNIV,SCH MED,DEPT INTERNAL MED,NEW ORLEANS,LA 70112
[5] UNIV CALIF LOS ANGELES,MED CTR,DEPT SURG,LOS ANGELES,CA 90024
[6] UNIV CALIF LOS ANGELES,MED CTR,DEPT PHARMACOL,LOS ANGELES,CA 90024
关键词
PULMONARY VASCULAR BED; ADENOSINE 5'-TRIPHOSPHATE-ACTIVATED POTASSIUM CHANNELS; POTASSIUM CHANNELS; TACHYPHYLAXIS; PULMONARY VASODILATION; SYSTEMIC VASODILATION; ENDOTHELIUM-DERIVED RELAXING FACTOR;
D O I
10.1152/jappl.1993.75.1.38
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The present study was undertaken to compare and contrast the characteristics of the pulmonary and systemic vascular responses to endothelin (ET) isoforms in the intact spontaneously breathing cat under conditions of constant pulmonary blood flow and left atrial pressure. When pulmonary vasomotor tone (PVT) was actively increased by intralobar infusion of U-46619, intralobar arterial bolus injections of 1 mug ET-1, 1 mug ET-2, or 3 mug ET-3 markedly decreased lobar arterial pressure, systemic arterial pressure, and systemic vascular resistance. After seven repeated injections of ET-1 or ET-2 to separate groups of cats, pulmonary and systemic responses were largely reversed from vasodilation to vasoconstriction. In contrast, the pulmonary vasodilator response to ET-3 remained intact after multiple ET-3 injections, whereas its systemic vasodilator response was lost. Repeated intralobar arterial bolus injections of ET-1, ET-2, or ET-3 also caused the loss of pulmonary vasodilation to subsequent doses of ET-1, ET-2, or sarafotoxin 6b but not to ET-3. The present data suggest that the pulmonary and systemic vasodilator responses to ET-1 and ET-2 undergo tachyphylaxis and cross-tachyphylaxis. In contrast, the pulmonary vasodilator response to ET-3, unlike its systemic vasodilator response, is resistant to tachyphylaxis and cross-tachyphylaxis. The present data provide a functional correlate for the existence of at least two ET receptor subtypes, ET(A)-like and ET(C)-like receptors, in the adult pulmonary vascular bed.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 37 条
[1]   SOLUBILIZATION OF ENDOTHELIN SARAFOTOXIN RECEPTORS IN AN ACTIVE BINDING FORM [J].
AMBAR, I ;
KLOOG, Y ;
SOKOLOVSKY, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (1-2) :119-120
[2]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[3]   EVIDENCE FOR MULTIPLE ENDOTHELIN RECEPTORS IN THE GUINEA-PIG PULMONARY-ARTERY AND TRACHEA [J].
CARDELL, LO ;
UDDMAN, R ;
EDVINSSON, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (02) :376-380
[4]   ANALYSIS OF ENDOTHELIN-1-INDUCED CONTRACTIONS OF GUINEA-PIG TRACHEA, PULMONARY VEINS AND DIFFERENT TYPES OF PULMONARY-ARTERIES [J].
CARDELL, LO ;
UDDMAN, R ;
EDVINSSON, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1990, 139 (01) :103-111
[5]   TONE-DEPENDENT RESPONSES TO ENDOTHELIN IN THE ISOLATED PERFUSED FETAL SHEEP PULMONARY CIRCULATION INSITU [J].
CASSIN, S ;
KRISTOVA, V ;
DAVIS, T ;
KADOWITZ, P ;
GAUSE, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 70 (03) :1228-1234
[6]  
CAVERO I, 1989, J PHARMACOL EXP THER, V248, P1261
[7]   IMMUNOREACTIVE ENDOTHELIN IN HUMAN-PLASMA - MARKED ELEVATIONS IN PATIENTS IN CARDIOGENIC-SHOCK [J].
CERNACEK, P ;
STEWART, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :562-567
[8]   GLIBENCLAMIDE IS A COMPETITIVE ANTAGONIST OF THE THROMBOXANE A2 RECEPTOR IN DOG CORONARY-ARTERY INVITRO [J].
COCKS, TM ;
KING, SJ ;
ANGUS, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (02) :375-378
[9]   ENDOTHELIN - A NEW FAMILY OF ENDOTHELIUM-DERIVED PEPTIDES WITH WIDESPREAD BIOLOGICAL PROPERTIES [J].
DEGOUVILLE, ACL ;
LIPPTON, HL ;
CAVERO, I ;
SUMMER, WR ;
HYMAN, AL .
LIFE SCIENCES, 1989, 45 (17) :1499-1513
[10]  
DEGOUVILLE ACL, 1990, J PHARMACOL EXP THER, V254, P1024